![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](sj2533contents.gif)
Acta Cryst. (2008). E64, m1234-m1235 [ doi:10.1107/S1600536808027700 ]
Abstract: The title compound, (C4H8N3O)[Cr(C7H3NO4)2]·C7H5NO4·6H2O, was obtained by the reaction of Cr(NO3)3·9H2O with pyridine-2,6-dicarboxylic acid (pydcH2) and creatinine (creat) in aqueous solution (molar ratio 1:2:2). The cation is a protonated creatinine (creatH+) while the anion is a bis-pydc2- CrIII complex. The CrIII is coordinated by four oxygen and two nitrogen atoms of two (pydc)2- groups and has a disorted octahedral coordination environment. The structure also contains a neutral molecule of pydcH2 that is hydrogen bonded to the creatH+ and six molecules of water. Extensive intermolecular interactions, including seventeen classical hydrogen bonds, two weak C-H
O bonds, and C-O
stacking interactions, with O
centroid distances of 3.211 (13) and 3.300 (12) Å, connect the various components in the crystal structure.
Online 6 September 2008
Copyright © International Union of Crystallography
IUCr Webmaster